About Cancer Research KI

Background

In 2009 the Swedish Government designated in the Government Bill on Research Policy that 20 strategic research areas were to be prioritized; Cancer was one area. Cancer is represented nationally by three programmes: Cancer Research KI (formerly StratCan) at Karolinska Institutet, U-CAN (Universities of Uppsala & Umeå) and BioCare (Universities of Lund & Gothenburg).

Cancer as a strategic research area is motivated by the fact that cancer is one of the world's most common diseases and a major cause of death. In Sweden it is expected that cancer incidence will continue to rise and that cancer prevalence will double by 2030. New research strategies aiming at effective prevention and improved treatment are therefore urgently needed.

Organisation

Cancer Research KI was formed 2019 as the Strategic Research Programme in Cancer (StratCan) and the KICancer network joined forces. The programme is supported by the government through the strategic initiatives.

Cancer Research KI Steering Board:

Cancer research KI executive board members are holding positions at active cancers research departments involved in clinical, pre-clinical and epidemiological research at the southern and northern campus of Karolinska Insitutet, some members hold dual affiliations both at the Karolinska Institutet and the Karolinska University Hospital as reflected in the present list of members.

Two of the Cancer Research KI members are also members of the Board for the Cancer Theme at the Karolinska University hospital.